Article citationsMore >>

Al-Toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE, Ossenkoppele GJ, Huijgens PC, Mulder CJ. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007; 109: 2243-49.

has been cited by the following article:

Article

Complete Resolution of Type 1 Refractory Celiac Disease after Combined Treatment with Budesonide and Azathioprine: A Case Report and Literature Review

1Gastroenterology Section, Internal Medicine Department, Centro de Educación Médica e Investigación Clínica (CEMIC), Buenos Aires, Argentina


International Journal of Celiac Disease. 2015, Vol. 3 No. 1, 40-43
DOI: 10.12691/ijcd-3-1-3
Copyright © 2015 Science and Education Publishing

Cite this paper:
Juan Sebastian Lasa. Complete Resolution of Type 1 Refractory Celiac Disease after Combined Treatment with Budesonide and Azathioprine: A Case Report and Literature Review. International Journal of Celiac Disease. 2015; 3(1):40-43. doi: 10.12691/ijcd-3-1-3.

Correspondence to: Juan  Sebastian Lasa, Gastroenterology Section, Internal Medicine Department, Centro de Educación Médica e Investigación Clínica (CEMIC), Buenos Aires, Argentina. Email: drjuanslasa@gmail.com

Abstract

Refractory Celiac Disease is a rare condition associated with a substancial mortality rate. Both treatment and follow-up are still matter of debate. The case of a 54 year-old man with refractory celiac disease is presented who required treatment with both budesonide and azathioprine. A concise review of the clinical Management of Refractory Celiac Disease is then performed.

Keywords